Abstract Brucellosis is a zoonotic infection transmitted to humans from infected animals and is one of the widely spread zoonoses. Recently, six species were recognized within the genus Brucella wherein B. melitensis, B. suis and B. abortus are considered virulent for humans. While these species differ phenotypically by their pattern of metabolic activities, there has been an imperative need to understand pathogenesis of Brucella species. It has been foreseen that creating a human vaccine for Brucellosis would entail decreased dose of antibiotics. However the emerging role of Brucella pathogenesis still centers on isolation of the organism and various diagnostic tests thereby leading to varying strategies of treatment cycle. In view of disease heterogeneity, we focus systems and synthetic biology challenges that might improve our understanding the Brucella pathogenesis.
Introduction
Brucellosis caused by Brucella spp. is an endemic and neglected disease. Many countries have controlled brucellosis systematically using variant smooth live vaccines and immunization protocols. In the recent past, there has been an increase in alarming rate of seroprevalence in strains affecting both human and cattle, with the latter proving to be disastrous for agricultural growth (Moreno 2014) . Although complete genomes were obtained for many Brucella species, however not all these data are adequate to understand the bacterial pathogenesis leading to genomewide association studies (Shevtsov et al. 2013; Shome et al. 2013) . Besides, our understanding of genetic variation and epidemiology advanced with next generation sequencing (NGS) of Brucella spp., and provided a challenge to understand the sequences of these genomes better. Brucella employs systems to deliver DNA or proteins into the host cells which are assumed to have a critical role in bacterial virulence. The Type IV secretion systems (T4SS) are among the specialized macromolecule delivery machines. It is known that the VirB T4SS in Brucella spp. leads to development of pathogenesis in the formation of a niche inside host cell and is involved in effective protein translocation across the cell envelope (Lacerda et al. 2013) .
First challenge we see is how intracellular pathogenesis has been, to discriminate bacteria from host cell material. In recent times, a case study on how the effector role of T4SS in intracellular pathogens in relation to the functional genomics perspective is considered (Hanna et al. 2011) . Furthermore from the existing Brucella data that is available, we found that on an average there are about 600 known unknown (KU) or hypothetical proteins in Brucella spp. which might be linked to several functional pathways (See Supplementary Table S1 ). Additionally, we found that a few of these proteins are mapped to sulfate transport system permeases (CysT) and secretory systems, while a small number of them are linked to a role regulating synthetases and methyltransferases (See Supplementary Table  S1 ). Comparison of these proteins across all Brucella spp. could be interesting to understand if there are unique differences that map to the genomic peers.
Second, we suggest integrating the system-wide omics' approaches to find interconnections between the proteins representing Brucella immune response and virulence factors. From the preliminary searches, we confirm that these KUs may be involved in pathogenesis linking to synthetases, methyltransferases and other hypothetical proteins across Brucella spp. (See Fig. 1 ). This is available with previous searches from interaction pairs and therefore we consider it important to discuss function of tRNAs/rRNA synthetases and methyltransferases in Brucella (See Supplementary Table S2 ). One can design a bioinformatics tool or visualizer for protein targets specific to these pathogenic bacteria based on the available interaction data from its peers or orthologues. This system-wide omics' approach would considerably improve the translation of bioinformatics data generated into wet-lab experiments for predicting better drug targets. Additionally, it will allow us to significantly enhance understanding the immune response by providing a synthetic biology framework and systems biology foundation in associating candidate pathogens linked to antigenicity (Liang et al. 2011) . Furthermore, synthetases could be potential co-targets for many proteins (*synthetome) with their predicted role in initiating resistance for multiple drugs. Such targets were earlier shown to form a class of 'resistome' proteins and have been extensively identified in Mycobacterium (Padiadpu et al. 2010 ). In conclusion, protein-protein interaction networks constituting a synthetome imply that various targets with different propensities induce drug resistance in them.
Third, we asked if there are any identifiable clustered regularly interspaced short palindromic repeats (CRISPR) associated genes in Brucella. The publicly available database on CRISPR-associated (Cas) genes (See web reference) reveal that there is at least one each questionable structure in a majority of Brucella spp. indicating that Brucella might participate in a mechanism of acquired resistance against phages (de Barsy and Greub 2013) . This is augmented by the presence of diguanylate cyclase, GGDEF domains in Brucella which raises an interesting possibility that CRISPR system may perhaps have emerged to event pathogenesis. Fourth, Brucella spp. possesses operons with several components involved in regulatory subunits that are encoded by KU genes. Recently, one such study on interpreting the function of the BMEI0067, an uncharacterized protein conserved in bacteria was made (Liu et al. 2014) . Can structural biology validate such hypothetical proteins that might fundamentally be involved in regulating function? We have earlier looked at the prospects of hypothetical proteins relating pseudogenes to make novel synthetic molecules (Shidhi et al. 2014 ). This will hold a great promise in identifying them as biomarkers and further making better drug targets.
Conclusions
This is a time of great prospective for the control of brucellosis considered among one of the seven neglected endemic zoonoses by WHO (See web reference). From a practical viewpoint, the most coherent approach for preventing Brucellosis in human is the control and elimination of the infection in animals, which unfortunately is still in its infancy in developing countries. An important assumption of the Brucella pathogenesis can be attributed to the number of 'hidden' proteins in the form of KU genes that might allow the pathogen to elicit inflammatory responses further suppressing host immune response (Tian et al. 2013) . With the availability of bioinformatics high throughput prediction, understanding the molecular interactions with host cell would be promising to study the above-mentioned points of view. Nevertheless, a few questions about the biology of Brucella spp. continue to be answered, on (a) why and how diversely Brucella spp. display their specific host preference and (b) whether or not any of them suddenly develop mechanisms of pathogenesis. Such a conclusion must be strengthened by the addition of wet-lab experiments after systems-wide in silico approaches so that underlying causes for brucellosis in the hosts can be better explained. Recent NGS projects have produced a large scale data which would play a major role in understanding and identifying function of candidate KU genes. This would further allow us to comprehend underlying traits of 'diseasome' approach which holds a great promise. In so doing, a sincere hope is that the drug for brucellosis can be resolved amid all risk factors where the use of more than one antibiotic can be negated.
